Kyle Bryant was diagnosed with Friedreich's Ataxia, or FA, at 17 years old. Friedreich's Ataxia is a a rare neuromuscular disease that affects 1 in 50,000 people. Over the last ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the "Company”), a life sciences company developing precision genetic medicines for ...

Solid Biosciences Inc.’s SLDB share price has dipped by 14.97%, which has investors questioning if this is right time to buy.

Microsoft is rolling out a new sign-in screen for more than a billion consumers that access services like Outlook, Windows, Xbox, Microsoft 365, and more. The updated authentication screen is ...

Lexeo Therapeutics, Inc.’s LXEO share price has dipped by 10.14%, which has investors questioning if this is right time to buy.

March 26 (UPI) --A British man has become an unlikely hero on social media after he took it upon himself to repair a McDonald's restaurant sign that had become an object of curiosity for a ...

After getting a green light from the European Commission, Biogen’s Skyclarys is the first approved medicine for the inherited neurological disease Friedreich’s ataxia (FA) in the EU.

Unlike the rest of his family, he never rode in a helicopter. Donations in his memory may be made to the Friedreich’s Ataxia Research Alliance, 533 W. Uwchlan Ave, Downingtown, PA, 19335 (or ...

IPC Indice de Precios Y Cotizaciones 53,172.97-304.77-0.57% ...

DAX Futures 22441.00-238.00-1.05% ...